Discussion about new collateral therapies enabling a more targeted release of dopamine in the areas of the brain affected by neurodegenerative diseases.
Vania Broccoli
A graduate in Biological Sciences with a doctorate in Genetic Sciences, she is head of the Stem Cells and Neurogenesis